247 related articles for article (PubMed ID: 21238657)
1. Elements of successful intestinal rehabilitation.
Sigalet D; Boctor D; Brindle M; Lam V; Robertson M
J Pediatr Surg; 2011 Jan; 46(1):150-6. PubMed ID: 21238657
[TBL] [Abstract][Full Text] [Related]
2. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease.
Sigalet D; Boctor D; Robertson M; Lam V; Brindle M; Sarkhosh K; Driedger L; Sajedi M
Eur J Pediatr Surg; 2009 Dec; 19(6):348-53. PubMed ID: 19866409
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
Gura KM; Lee S; Valim C; Zhou J; Kim S; Modi BP; Arsenault DA; Strijbosch RA; Lopes S; Duggan C; Puder M
Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
[TBL] [Abstract][Full Text] [Related]
4. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.
Rollins MD; Scaife ER; Jackson WD; Meyers RL; Mulroy CW; Book LS
Nutr Clin Pract; 2010 Apr; 25(2):199-204. PubMed ID: 20413701
[TBL] [Abstract][Full Text] [Related]
5. Some new insights in intestinal failure-associated liver disease.
Goulet O; Joly F; Corriol O; Colomb-Jung V
Curr Opin Organ Transplant; 2009 Jun; 14(3):256-61. PubMed ID: 19444108
[TBL] [Abstract][Full Text] [Related]
6. The use of Omegaven in treating parenteral nutrition-associated liver disease.
Park KT; Nespor C; Kerner J
J Perinatol; 2011 Apr; 31 Suppl 1():S57-60. PubMed ID: 21448206
[TBL] [Abstract][Full Text] [Related]
7. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.
Gura KM; Duggan CP; Collier SB; Jennings RW; Folkman J; Bistrian BR; Puder M
Pediatrics; 2006 Jul; 118(1):e197-201. PubMed ID: 16818533
[TBL] [Abstract][Full Text] [Related]
8. Surgical intervention in the setting of parenteral nutrition-associated cholestasis may exacerbate liver injury.
Arsenault DA; Potemkin AK; Robinson EM; Fallon EM; Ozonoff A; de Meijer VE; Puder M
J Pediatr Surg; 2011 Jan; 46(1):122-7. PubMed ID: 21238652
[TBL] [Abstract][Full Text] [Related]
9. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
Orso G; Mandato C; Veropalumbo C; Cecchi N; Garzi A; Vajro P
Dig Liver Dis; 2016 Mar; 48(3):215-22. PubMed ID: 26698410
[TBL] [Abstract][Full Text] [Related]
10. Prevention and reversal of intestinal failure-associated liver disease in premature infants with short bowel syndrome using intravenous fish oil in combination with omega-6/9 lipid emulsions.
Lilja HE; Finkel Y; Paulsson M; Lucas S
J Pediatr Surg; 2011 Jul; 46(7):1361-7. PubMed ID: 21763835
[TBL] [Abstract][Full Text] [Related]
11. Preventing parenteral nutrition liver disease.
Kelly DA
Early Hum Dev; 2010 Nov; 86(11):683-7. PubMed ID: 20923719
[TBL] [Abstract][Full Text] [Related]
12. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
[TBL] [Abstract][Full Text] [Related]
13. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM
J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
[TBL] [Abstract][Full Text] [Related]
14. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease.
de Meijer VE; Gura KM; Meisel JA; Le HD; Puder M
Arch Surg; 2010 Jun; 145(6):547-51. PubMed ID: 20566974
[TBL] [Abstract][Full Text] [Related]
15. An exclusively based parenteral fish-oil emulsion reverses cholestasis.
Triana Junco M; García Vázquez N; Zozaya C; Ybarra Zabala M; Abrams S; García de Lorenzo A; Sáenz de Pipaón Marcos M
Nutr Hosp; 2014 Oct; 31(1):514-6. PubMed ID: 25561149
[TBL] [Abstract][Full Text] [Related]
16. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid.
Cheung HM; Lam HS; Tam YH; Lee KH; Ng PC
Clin Nutr; 2009 Apr; 28(2):209-12. PubMed ID: 19261360
[TBL] [Abstract][Full Text] [Related]
17. What is the current role for parenteral lipid emulsions containing omega-3 fatty acids in infants with short bowel syndrome?
Diamond IR; Pencharz PB; Wales PW
Minerva Pediatr; 2009 Jun; 61(3):263-72. PubMed ID: 19461570
[TBL] [Abstract][Full Text] [Related]
18. Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study.
Pawlik D; Lauterbach R; Walczak M; Hurkała J; Sherman MP
JPEN J Parenter Enteral Nutr; 2014 Aug; 38(6):711-6. PubMed ID: 23963690
[TBL] [Abstract][Full Text] [Related]
19. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.
Puder M; Valim C; Meisel JA; Le HD; de Meijer VE; Robinson EM; Zhou J; Duggan C; Gura KM
Ann Surg; 2009 Sep; 250(3):395-402. PubMed ID: 19661785
[TBL] [Abstract][Full Text] [Related]
20. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil.
Fallon EM; Le HD; Puder M
Curr Opin Organ Transplant; 2010 Jun; 15(3):334-40. PubMed ID: 20503524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
